clinmedКлиническая медицинаClinical Medicine (Russian Journal)0023-21492412-1339ООО «Медицинское информационное агентство»10.30629/0023-2149-2022-100-6-253-260clinmed-391Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESПатогенетические и клинические аспекты сочетания артериальной гипертензии и фибрилляции предсердийArterial hypertension and atrial fi brillation: general pathogenesis and mutual eff ects on the course of diseasesОвчинниковЮ. В.OvchinnikovYu. V.

Юрий Викторович Овчинников, д-р мед. наук, профессор, профессор кафедры

ФГБВОУ ВО «Филиал Военно-медицинской академии имени С. М. Кирова в г. Москве»

кафедра терапии неотложных состояний

107392

Москва

Yuri V. Ovchinnikov

Branch of the Military Medical Academy named after S. M. Kirov in Moscow

107392

Moscow

ovchinnikov.munkc@mail.ruПаценкоМ. Б.PatsenkoM. B.

Михаил Борисович Паценко, канд. мед. наук, доцент, главный терапевт, начальник кафедры

ФГБВОУ ВО «Филиал Военно-медицинской академии имени С. М. Кирова в г. Москве»

кафедра терапии неотложных состояний

107392

Москва

Mikhail B. Patsenko

Branch of the Military Medical Academy named after S. M. Kirov in Moscow

107392

Moscow

АнучкинА. А.AnuchkinA. A.

Александр Анатольевич Анучкин, канд. мед. наук, доцент, заместитель начальника кафедры

ФГБВОУ ВО «Филиал Военно-медицинской академии имени С. М. Кирова в г. Москве»

кафедра терапии неотложных состояний

107392

Москва

Alexander A. Anuchkin

Branch of the Military Medical Academy named after S. M. Kirov in Moscow

107392

Moscow

ПавловаЕ. М.PavlovaE. M.

Екатерина Михайловна Павлова,  слушатель клинической ординатуры

ФГБВОУ ВО «Филиал Военно-медицинской академии имени С. М. Кирова в г. Москве»

кафедра терапии неотложных состояний

107392

Москва

Ekaterina M. Pavlova

Branch of the Military Medical Academy named after S. M. Kirov in Moscow

107392

Moscow

Минобороны РоссииРоссияMinistry of Defense of RussiaRussian Federation2022140920221006253260Copyright © Овчинников Ю.В., Паценко М.Б., Анучкин А.А., Павлова Е.М., 20222022Овчинников Ю.В., Паценко М.Б., Анучкин А.А., Павлова Е.М.Ovchinnikov Y.V., Patsenko M.B., Anuchkin A.A., Pavlova E.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.clinmedjournal.com/jour/article/view/391

   В статье представлен обзор современных научных публикаций, посвященных вопросам патогенеза фибрилляции предсердий (ФП) у больных артериальной гипертензией (АГ), а также вопросам контроля артериального давления при ФП. Артериальная гипертензия (АГ) часто сопровождается сопутствующей патологией и, кроме того, является наиболее частым фактором развития фибрилляции предсердий (ФП). ФП — самый распространенный вид аритмии, который способствует увеличению риска развития тромбоэмболических осложнений, сердечной недостаточности и приводит к увеличению общего уровня смертности.

   Целью работы являлось изучение патологических механизмов формирования ФП при АГ, а также взаимные влияния на течение заболеваний, кроме того, анализ и сравнение методов измерения артериального давления (АД) при ФП, используемых в современной клинической работе, и выявление наиболее объективного метода.

   Для достижения поставленной цели применен общенаучный метод: анализ современной научной отечественной и зарубежной литературы по проблемам исследования, обобщение, сравнение, систематизация теоретических данных об опыте применения. Все обзоры были индексированы в базах данных PubMed, Medline, eLibrary, CyberLeninka, Google Scholar. Представленное исследование позволило сделать выводы о том, что АГ является как фактором риска возникновения фибрилляции предсердий, так и осложнением течения заболевания у пациентов с фибрилляций предсердий; наиболее объективным методом измерения АД при ФП является осциллометрический. Выявлены задачи и перспективы будущих исследований.

    The article presents reviews of modern domestic and foreign scientific publications on the pathogenesis of atrial fibrillation (AF) in patients with arterial hypertension (AH), as well as the issues of blood pressure control in AF. Arterial hypertension (AH) is often accompanied by comorbidity, and, in addition, is the most frequent factor in the development of atrial fibrillation (AF). AF is the most common type of arrhythmia, which increases the risk of thromboembolic complications, heart failure, and leads to an increase in the overall mortality rate.

   The aim of the work was to study the pathological mechanisms of the formation of AF in hypertension, as well as their mutual impact on the course of diseases, and, in addition, to analyze and compare methods for measuring blood pressure (BP) in AF, used in modern clinical work, to identify the most objective method.

   A general scientific method was applied: analysis of modern scientifi c domestic and foreign literature on research problems, generalization, comparison, systematization of theoretical data on the experience of application. All reviews were indexed in PubMed, Medline, eLibrary, CyberLeninka, Google Scholar databases. The presented study allow us to conclude that hypertension is both a risk factor for atrial fi brillation and a complication of the course of the disease in patients with atrial fibrillation; the most objective method of measuring blood pressure in AF is oscillometric. The tasks and prospects of future research are identified.

артериальная гипертензияфибрилляция предсердийгипертоническая болезньаритмияпатогенезосциллометрияаrterial hypertensionatrial fi brillationpathogenesisarrhythmiaoscillometryИсследование не имело спонсорской поддержкиThe study had no sponsorshipReferencesЧазова И. Е. Распространенность ФР сердечно-сосудистых заболеваний в Pоссийской популяции больных артериальной гипертонией / И. Е. Чазова [и др.] // Кардиология. – 2014. –10: 4–12. [Chazova I. E., Zhernakova Yu. V., Oshchepkova E. V., Shalnova S. A., Yarovaya E. B., Konradi A. O., etc. The prevalence of FR of cardiovascular diseases in the Russian population of patients with arterial hypertension. Cardiology. 2014; 10: 4–12. (In Russian)]. URL: https://pubmed.ncbi.nlm.nih.gov/25675714/Чазова И. Е. Распространенность ФР сердечно-сосудистых заболеваний в Pоссийской популяции больных артериальной гипертонией / И. Е. Чазова [и др.] // Кардиология. – 2014. –10: 4–12. [Chazova I. E., Zhernakova Yu. V., Oshchepkova E. V., Shalnova S. A., Yarovaya E. B., Konradi A. O., etc. The prevalence of FR of cardiovascular diseases in the Russian population of patients with arterial hypertension. Cardiology. 2014; 10: 4–12. (In Russian)]. URL: https://pubmed.ncbi.nlm.nih.gov/25675714/Mills K. T., Bundy J. D., Kelly T. N., Reed J. E., Kearney P. M., Reynolds K. et al. Global disparities of hypertension prevalence and control. Circulation. 2016; 134: 441–50. DOI: 10.1161/CIRCULATIONAHA.115.018912Mills K. T., Bundy J. D., Kelly T. N., Reed J. E., Kearney P. M., Reynolds K. et al. Global disparities of hypertension prevalence and control. Circulation. 2016; 134: 441–50. DOI: 10.1161/CIRCULATIONAHA.115.018912Williams B., Mancia G., Spiering W. et al. 2018 ESC / ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 2018; 39 (33): 3021–3104. DOI: 10.1093/eurheartj/ehy339Williams B., Mancia G., Spiering W. et al. 2018 ESC / ESH Guidelines for the management of arterial hypertension. Eur. Heart J. 2018; 39 (33): 3021–3104. DOI: 10.1093/eurheartj/ehy339Mozaff arian D., Benjamin E. J., Go A. S., Arnett D. K., Blaha M. J., Cushman M. et al. Executive summary: heart disease and stroke statistics—2016 Update. Circulation. 2016; 133: 447–54. DOI: 10.1161/CIR.0000000000000366Mozaff arian D., Benjamin E. J., Go A. S., Arnett D. K., Blaha M. J., Cushman M. et al. Executive summary: heart disease and stroke statistics—2016 Update. Circulation. 2016; 133: 447–54. DOI: 10.1161/CIR.0000000000000366Chow C. K., Teo K. K., Rangarajan S., Islam S., Gupta R., Avezum A. et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013; 310 (9): 959–68. DOI: 10.1001/jama.2013.184182Chow C. K., Teo K. K., Rangarajan S., Islam S., Gupta R., Avezum A. et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013; 310 (9): 959–68. DOI: 10.1001/jama.2013.184182Lindholt J. S., Søgaard R. Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial. Lancet. 2017; 390 (10109): 2256–65. DOI: 10.1016/S0140-6736(17)32250-XLindholt J. S., Søgaard R. Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial. Lancet. 2017; 390 (10109): 2256–65. DOI: 10.1016/S0140-6736(17)32250-XBenjamin E. J., Levy D., Vaziri S. M., D’agostino R. B., Belanger A. J., Wolf P. A. Independent risk factors for atrial fibrillation in a population-based cohort: the framingham heart study. JAMA. 1994; 271: 840–4.Benjamin E. J., Levy D., Vaziri S. M., D’agostino R. B., Belanger A. J., Wolf P. A. Independent risk factors for atrial fibrillation in a population-based cohort: the framingham heart study. JAMA. 1994; 271: 840–4.Huxley R. R., Lopez F. L., Folsom A. R., Agarwal S. K., Loehr L. R., Soliman E. Z. et al. Absolute and attributable risks of atrial fi brillation in relation to optimal and borderline risk factors. Circulation. 2011; 123: 1501–8. DOI: 10.1161/CIRCULATIONAHA.110.009035Huxley R. R., Lopez F. L., Folsom A. R., Agarwal S. K., Loehr L. R., Soliman E. Z. et al. Absolute and attributable risks of atrial fi brillation in relation to optimal and borderline risk factors. Circulation. 2011; 123: 1501–8. DOI: 10.1161/CIRCULATIONAHA.110.009035Emdin C. A., Callender T., Cao J., Rahimi K. Effect of antihypertensive agents on risk of atrial fi brillation: a meta-analysis of large-scale randomized trials. Europace. 2015; 17: 701–10. DOI: 10.1093/europace/euv021.Emdin C. A., Callender T., Cao J., Rahimi K. Effect of antihypertensive agents on risk of atrial fi brillation: a meta-analysis of large-scale randomized trials. Europace. 2015; 17: 701–10. DOI: 10.1093/europace/euv021.Andersson T., Magnuson A., Bryngelsson I.-L., Frøbert O., Henriksson K. M., Edvardsson N. et al. All-cause mortality in 272186 patients hospitalized with incident atrial fi brillation 1995–2008: a Invited review: hypertension and atrial fi brillation: epidemiology, pathophysiology, and implications. Swedish nationwide long-term case–control study. Eur. Heart J. 2013; 34: 1061–7. DOI: 10.1093/eurheartj/ehs469Andersson T., Magnuson A., Bryngelsson I.-L., Frøbert O., Henriksson K. M., Edvardsson N. et al. All-cause mortality in 272186 patients hospitalized with incident atrial fi brillation 1995–2008: a Invited review: hypertension and atrial fi brillation: epidemiology, pathophysiology, and implications. Swedish nationwide long-term case–control study. Eur. Heart J. 2013; 34: 1061–7. DOI: 10.1093/eurheartj/ehs469Charitakis E., Barmano N., Walfridsson U., Walfridsson H. Factors predicting arrhythmia-related symptoms and health-related quality of life in patients referred for radiofrequency ablation of atrial fibrillation. JACC Clin. Electrophysiol. 2017; 3: 494–502. DOI: 10.1016/j.jacep.2016.12.004Charitakis E., Barmano N., Walfridsson U., Walfridsson H. Factors predicting arrhythmia-related symptoms and health-related quality of life in patients referred for radiofrequency ablation of atrial fibrillation. JACC Clin. Electrophysiol. 2017; 3: 494–502. DOI: 10.1016/j.jacep.2016.12.004Шидловская С. А. Опыт применения объемной компрессионной осциллометрии у пациентов с артериальной гипертензией / С. А. Шидловская [и др.] // Кардиология и сердечно-сосудистая хирургия. –2015. – 8 (2): 33–37. [Shidlovskaya S. A., Lebedeva L. B., Degtyarev V. A., Chomakhidze P. S., Kopylov F. Yu. Experience in the use of volumetric compression oscillometry in patients with arterial hypertension. Cardiology and cardiovascular surgery. 2015; 8 (2): 33–37. (In Russian)]. DOI: 10.17116/kardio20158233-37Шидловская С. А. Опыт применения объемной компрессионной осциллометрии у пациентов с артериальной гипертензией / С. А. Шидловская [и др.] // Кардиология и сердечно-сосудистая хирургия. –2015. – 8 (2): 33–37. [Shidlovskaya S. A., Lebedeva L. B., Degtyarev V. A., Chomakhidze P. S., Kopylov F. Yu. Experience in the use of volumetric compression oscillometry in patients with arterial hypertension. Cardiology and cardiovascular surgery. 2015; 8 (2): 33–37. (In Russian)]. DOI: 10.17116/kardio20158233-37Chugh S. S., Havmoeller R., Narayanan K., Singh D., Rienstra M., Benjamin E. J. et al. Worldwide epidemiology of atrial fi brillation. Circulation. 2014; 129: 837–47. DOI: 10.1161/CIRCULATIONAHA.113.005119Chugh S. S., Havmoeller R., Narayanan K., Singh D., Rienstra M., Benjamin E. J. et al. Worldwide epidemiology of atrial fi brillation. Circulation. 2014; 129: 837–47. DOI: 10.1161/CIRCULATIONAHA.113.005119Go A. S., Hylek E. M., Phillips K. A., Chang Y., Henault L. E., Selby J. V. et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation. JAMA. 2001; 285 (18): 2370–5. DOI: 10.1001/jama.285.18.2370Go A. S., Hylek E. M., Phillips K. A., Chang Y., Henault L. E., Selby J. V. et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation. JAMA. 2001; 285 (18): 2370–5. DOI: 10.1001/jama.285.18.2370Rahman F., Yin X., Larson M. G., Ellinor P. T., Lubitz S. A., Vasan R. S., McManus D. D., Magnani J. W., Benjamin E. J. Trajectories of Risk Factors and Risk of New-Onset Atrial Fibrillation in the Framingham Heart Study. Hypertension. 2016; 68 (3): 597–605. DOI: 10.1161/HYPERTENSIONAHA.116.07683Rahman F., Yin X., Larson M. G., Ellinor P. T., Lubitz S. A., Vasan R. S., McManus D. D., Magnani J. W., Benjamin E. J. Trajectories of Risk Factors and Risk of New-Onset Atrial Fibrillation in the Framingham Heart Study. Hypertension. 2016; 68 (3): 597–605. DOI: 10.1161/HYPERTENSIONAHA.116.07683Gorenek B., Pelliccia A., Benjamin E. J., Boriani G., Crijns H. J., Fogel R. I. et al. European Heart Rhythm Association (EHRA) / European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacifi c Heart Rhythm Society (APHRS). Europace. 2017; 19: 190–225. DOI: 10.1093/europace/euw242Gorenek B., Pelliccia A., Benjamin E. J., Boriani G., Crijns H. J., Fogel R. I. et al. European Heart Rhythm Association (EHRA) / European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacifi c Heart Rhythm Society (APHRS). Europace. 2017; 19: 190–225. DOI: 10.1093/europace/euw242Chamberlain A. M., Agarwal S. K., Ambrose M., Folsom A. R., Soliman E. Z., Alonso A. Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the atherosclerosis risk in communities (ARIC) Study. Am. Heart J. 2010; 159: 850–6. DOI: 10.1016/j.ahj.2010.02.005Chamberlain A. M., Agarwal S. K., Ambrose M., Folsom A. R., Soliman E. Z., Alonso A. Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the atherosclerosis risk in communities (ARIC) Study. Am. Heart J. 2010; 159: 850–6. DOI: 10.1016/j.ahj.2010.02.005Alonso A., Krijthe B. P., Aspelund T., Stepas K. A., Pencina M. J., Moser C. B. et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J. Am. Heart Assoc. 2013; 2 (2): e000102. DOI: 10.1161/JAHA.112.000102Alonso A., Krijthe B. P., Aspelund T., Stepas K. A., Pencina M. J., Moser C. B. et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J. Am. Heart Assoc. 2013; 2 (2): e000102. DOI: 10.1161/JAHA.112.000102de Vos C. B., Pisters R., Nieuwlaat R., Prins M. H., Tieleman R. G., Coelen R. J., van den Heijkant A. C., Allessie M. A., Crijns H. J. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J. Am. Coll. Cardiol. 2010; 55 (8): 725–31. DOI: 10.1016/j.jacc.2009.11.040de Vos C. B., Pisters R., Nieuwlaat R., Prins M. H., Tieleman R. G., Coelen R. J., van den Heijkant A. C., Allessie M. A., Crijns H. J. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J. Am. Coll. Cardiol. 2010; 55 (8): 725–31. DOI: 10.1016/j.jacc.2009.11.040Lip G. Y. H., Coca A., Kahan T., Boriani G., Manolis A. S., Olsen M. H. et al. Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamerican. Europace. 2017; 19: 891–911. DOI: 10.1093/europace/eux091. PMID: 28881872Lip G. Y. H., Coca A., Kahan T., Boriani G., Manolis A. S., Olsen M. H. et al. Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamerican. Europace. 2017; 19: 891–911. DOI: 10.1093/europace/eux091. PMID: 28881872Laukkanen J. A., Khan H., Kurl S., Willeit P., Karppi J., Ronkainen K. et al. Left ventricular mass and the risk of sudden cardiac death: a population‐based study. J. Am. Heart Assoc. 2014; 3: e001285. DOI: 10.1161/JAHA.114.001285Laukkanen J. A., Khan H., Kurl S., Willeit P., Karppi J., Ronkainen K. et al. Left ventricular mass and the risk of sudden cardiac death: a population‐based study. J. Am. Heart Assoc. 2014; 3: e001285. DOI: 10.1161/JAHA.114.001285Lip G. Y. H. Atrial Fibrillation in Patients With Hypertension trajectories of risk factors in yet another manifestation of hypertensive target organ damage. Hypertension. 2016; 68: 544–5. DOI: 10.1161/HYPERTENSIONAHA.116.07901Lip G. Y. H. Atrial Fibrillation in Patients With Hypertension trajectories of risk factors in yet another manifestation of hypertensive target organ damage. Hypertension. 2016; 68: 544–5. DOI: 10.1161/HYPERTENSIONAHA.116.07901Patel M. R., Mahaffey K. W., Garg J., Pan G., Singer D. E., Hacke W. et al. Rivaroxaban versus Warfarin in nonvalvular atrial fibrillation. N. Engl. J. Med. 2011; 365: 883–91. DOI: 10.1056/NEJMoa1009638. Epub 2011 Aug 10. PMID: 21830957Patel M. R., Mahaffey K. W., Garg J., Pan G., Singer D. E., Hacke W. et al. Rivaroxaban versus Warfarin in nonvalvular atrial fibrillation. N. Engl. J. Med. 2011; 365: 883–91. DOI: 10.1056/NEJMoa1009638. Epub 2011 Aug 10. PMID: 21830957Connolly S. J., Ezekowitz M. D., Yusuf S., Eikelboom J., Oldgren J., Parekh A. et al. Dabigatran versus Warfarin in patients with atrial fi brillation. N. Engl. J. Med. 2009; 361: 1139–51. DOI: 10.1056/NEJMoa0905561Connolly S. J., Ezekowitz M. D., Yusuf S., Eikelboom J., Oldgren J., Parekh A. et al. Dabigatran versus Warfarin in patients with atrial fi brillation. N. Engl. J. Med. 2009; 361: 1139–51. DOI: 10.1056/NEJMoa0905561Granger C. B., Alexander J. H., John M. H. S., et al. Apixaban versus Warfarin in patients with atrial fi brillation. N Engl J Med. 2011; 365: 683–93. DOI: 10.1056/NEJMOA1107039Granger C. B., Alexander J. H., John M. H. S., et al. Apixaban versus Warfarin in patients with atrial fi brillation. N Engl J Med. 2011; 365: 683–93. DOI: 10.1056/NEJMOA1107039Connolly S. J., Eikelboom J., Joyner C., Diener H.-C., Hart R., Golitsyn S. et al. Apixaban in patients with atrial fibrillation. N. Engl. J. Med. 2011; 364: 806–17. DOI: 10.1056/NEJMoa1007432Connolly S. J., Eikelboom J., Joyner C., Diener H.-C., Hart R., Golitsyn S. et al. Apixaban in patients with atrial fibrillation. N. Engl. J. Med. 2011; 364: 806–17. DOI: 10.1056/NEJMoa1007432Lopes R. D., Heizer G., Aronson R., Vora A. N., Massaro T., Mehran R. et al. Antithrombotic therapy after acute coronary syndrome or PCI in atrial fi brillation. N. Engl. J. Med. 2019; 380 (16): 1509–1524. DOI: 10.1056/NEJMoa1817083Lopes R. D., Heizer G., Aronson R., Vora A. N., Massaro T., Mehran R. et al. Antithrombotic therapy after acute coronary syndrome or PCI in atrial fi brillation. N. Engl. J. Med. 2019; 380 (16): 1509–1524. DOI: 10.1056/NEJMoa1817083Kannel W., Wolf P., Benjamin E., Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am. J. Cardiol. 1998; 82: 2N–9N. DOI: 10.1016/s0002-9149(98)00583-9.Kannel W., Wolf P., Benjamin E., Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am. J. Cardiol. 1998; 82: 2N–9N. DOI: 10.1016/s0002-9149(98)00583-9.Conen D., Tedrow U. B., Koplan B. A., Glynn R. J., Buring J. E., Albert C. M. Influence of systolic and diastolic blood pressure on the risk of incident atrial fi brillation in women. Circulation. 2009; 119: 2146–52. DOI: 10.1161/CIRCULATIONAHA.108.830042Conen D., Tedrow U. B., Koplan B. A., Glynn R. J., Buring J. E., Albert C. M. Influence of systolic and diastolic blood pressure on the risk of incident atrial fi brillation in women. Circulation. 2009; 119: 2146–52. DOI: 10.1161/CIRCULATIONAHA.108.830042Grundvold I., Skretteberg P. T., Liestøl K., Erikssen G., Kjeldsen S. E., Arnesen H. et al. Upper normal blood pressures predict incident atrial fibrillation in healthy middleaged men: a 35-year follow-up study. Hypertension. 2012; 59: 198–204. DOI: 10.1161/HYPERTENSIONAHA.111.179713Grundvold I., Skretteberg P. T., Liestøl K., Erikssen G., Kjeldsen S. E., Arnesen H. et al. Upper normal blood pressures predict incident atrial fibrillation in healthy middleaged men: a 35-year follow-up study. Hypertension. 2012; 59: 198–204. DOI: 10.1161/HYPERTENSIONAHA.111.179713Pathak R. K., Middeldorp M. E., Lau D. H., Mehta A. B., Mahajan R., Twomey D. et al., Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J. Am. Coll. Cardiol. 2014; 64: 2222–31. DOI: 10.1016/j.jacc.2014.09.028Pathak R. K., Middeldorp M. E., Lau D. H., Mehta A. B., Mahajan R., Twomey D. et al., Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J. Am. Coll. Cardiol. 2014; 64: 2222–31. DOI: 10.1016/j.jacc.2014.09.028Bettoni M., Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fi brillation. Circulation. 2002; 105: 2753–9. DOI: 10.1161/01.cir.0000018443.44005.d8Bettoni M., Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fi brillation. Circulation. 2002; 105: 2753–9. DOI: 10.1161/01.cir.0000018443.44005.d8Ogawa M., Zhou S., Tan A. Y., Song J., Gholmieh G., Fishbein M. C. et al. Left stellate ganglion and vagal nerve activity and cardiac arrhythmias in ambulatory dogs with pacing-induced congestive heart failure. J. Am. Coll. Cardiol. 2007; 50: 335–43. DOI: 10.1016/j.jacc.2007.03.045Ogawa M., Zhou S., Tan A. Y., Song J., Gholmieh G., Fishbein M. C. et al. Left stellate ganglion and vagal nerve activity and cardiac arrhythmias in ambulatory dogs with pacing-induced congestive heart failure. J. Am. Coll. Cardiol. 2007; 50: 335–43. DOI: 10.1016/j.jacc.2007.03.045Linz D., Ukena C., Mahfoud F., Neuberger H. R., Böhm M. Atrial autonomic innervation: a target for interventional antiarrhythmic therapy? J. Am. Coll. Cardiol. 2014; 63: 215–24. DOI: 10.1016/j.jacc.2013.09.020Linz D., Ukena C., Mahfoud F., Neuberger H. R., Böhm M. Atrial autonomic innervation: a target for interventional antiarrhythmic therapy? J. Am. Coll. Cardiol. 2014; 63: 215–24. DOI: 10.1016/j.jacc.2013.09.020Carpenter A., Frontera A., Bond R., Duncan E., Thomas G. Vagal atrial fi brillation: What is it and should we treat it? Int J Cardiol 2015; 201: 415–21. DOI: 10.1016/j.ijcard.2015.08.108Carpenter A., Frontera A., Bond R., Duncan E., Thomas G. Vagal atrial fi brillation: What is it and should we treat it? Int J Cardiol 2015; 201: 415–21. DOI: 10.1016/j.ijcard.2015.08.108Liang Z., Shi X., Liu L., Chen X., Shan Z., Lin K. et al. Renal denervation suppresses atrial fibrillation in a model of renal impairment. PLoS One. 2015; 10 (4): e0124123. DOI: 10.1371/journal.pone.0124123Liang Z., Shi X., Liu L., Chen X., Shan Z., Lin K. et al. Renal denervation suppresses atrial fibrillation in a model of renal impairment. PLoS One. 2015; 10 (4): e0124123. DOI: 10.1371/journal.pone.0124123Wei Y., Xu J., Zhou G., Chen S., Ouyang P., Liu S. Renal denervation suppresses the inducibility of atrial fibrillation in a rabbit model for atrial fi brosis. PLoS One. 2016; 11: e0160634. DOI: 10.1371/journal.pone.0160634Wei Y., Xu J., Zhou G., Chen S., Ouyang P., Liu S. Renal denervation suppresses the inducibility of atrial fibrillation in a rabbit model for atrial fi brosis. PLoS One. 2016; 11: e0160634. DOI: 10.1371/journal.pone.0160634Linz D., van Hunnik A., Hohl M., Mahfoud F., Wolf M., Neuberger H. R. et al. Catheter-based renal denervation reduces atrial nerve sprouting and complexity of atrial fi brillation in goats. Circ. Arrhythm. Electrophysiol. 2015; 8: 466–74. DOI: 10.1161/CIRCEP.114.002453Linz D., van Hunnik A., Hohl M., Mahfoud F., Wolf M., Neuberger H. R. et al. Catheter-based renal denervation reduces atrial nerve sprouting and complexity of atrial fi brillation in goats. Circ. Arrhythm. Electrophysiol. 2015; 8: 466–74. DOI: 10.1161/CIRCEP.114.002453Williams B., MacDonald T. M., Morant S., Webb D. J., Sever P., McInnes G. et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet. 2015; 386: 2059–68. DOI: 10.1016/S0140-6736(15)00257-3Williams B., MacDonald T. M., Morant S., Webb D. J., Sever P., McInnes G. et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet. 2015; 386: 2059–68. DOI: 10.1016/S0140-6736(15)00257-3Bhatt D. L., Kandzari D. E., O’Neill W. W., D’Agostino R., Flack J. M., Katzen B. T. et al. A controlled trial of renal denervation for resistant hypertension. N. Engl. J. Med. 2014; 370: 1393–401. DOI: 10.1056/NEJMoa1402670Bhatt D. L., Kandzari D. E., O’Neill W. W., D’Agostino R., Flack J. M., Katzen B. T. et al. A controlled trial of renal denervation for resistant hypertension. N. Engl. J. Med. 2014; 370: 1393–401. DOI: 10.1056/NEJMoa1402670Manolis A., Doumas M., Poulimenos L., Kallistratos M., Mancia G. The unappreciated importance of blood pressure in recent and older atrial fibrillation trials. J. Hypertens. 2013; 31 (11): 2109–2117. DOI: 10.1097/HJH.0b013e3283638194Manolis A., Doumas M., Poulimenos L., Kallistratos M., Mancia G. The unappreciated importance of blood pressure in recent and older atrial fibrillation trials. J. Hypertens. 2013; 31 (11): 2109–2117. DOI: 10.1097/HJH.0b013e3283638194Goette A., Kalman J. M., Aguinaga L., Akar J., Cabrera J. A., Chen S. A. et al. EHRA / HRS / APHRS/SOLAECE expert consensus on atrial cardiomyopathies: defi nition, characterization, and clinical implication. Europace. 2016; 18: 1455–90. DOI: 10.1093/europace/euw161Goette A., Kalman J. M., Aguinaga L., Akar J., Cabrera J. A., Chen S. A. et al. EHRA / HRS / APHRS/SOLAECE expert consensus on atrial cardiomyopathies: defi nition, characterization, and clinical implication. Europace. 2016; 18: 1455–90. DOI: 10.1093/europace/euw161Chatterjee S., Bavishi C., Sardar P., Agarwal V., Krishnamoorthy P., Grodzicki T. et al. Meta-analysis of left ventricular hypertrophy and sustained arrhythmias. Am. J. Cardiol. 2014; 114: 1049–52. DOI: 10.1016/j.amjcard.2014.07.015Chatterjee S., Bavishi C., Sardar P., Agarwal V., Krishnamoorthy P., Grodzicki T. et al. Meta-analysis of left ventricular hypertrophy and sustained arrhythmias. Am. J. Cardiol. 2014; 114: 1049–52. DOI: 10.1016/j.amjcard.2014.07.015Tremblay-Gravel M., White M., Roy D., Leduc H., Wyse D. G., Cadrin-Tourigny J. et al. Blood pressure and atrial fibrillation: a combined AF-CHF and AFFIRM analysis. J. Cardiovasc. Elec trophysiol. 2015; 26: 509–14. DOI: 10.1111/jce.12652Tremblay-Gravel M., White M., Roy D., Leduc H., Wyse D. G., Cadrin-Tourigny J. et al. Blood pressure and atrial fibrillation: a combined AF-CHF and AFFIRM analysis. J. Cardiovasc. Elec trophysiol. 2015; 26: 509–14. DOI: 10.1111/jce.12652Marott S. C. W., Nielsen S. F., Benn M., Nordestgaard B. G. Antihypertensive treatment and risk of atrial fibrillation: a nationwide study. Eur. Heart J. 2014; 35: 1205–14. DOI: 10.1093/eurheartj/eht507Marott S. C. W., Nielsen S. F., Benn M., Nordestgaard B. G. Antihypertensive treatment and risk of atrial fibrillation: a nationwide study. Eur. Heart J. 2014; 35: 1205–14. DOI: 10.1093/eurheartj/eht507Chatterjee S., Bavishi C., Sardar P., Agarwal V., Krishnamoorthy P., Grodzicki T. et al. Meta-analysis of left ventricular hypertrophy and sustained arrhythmias. Am. J. Cardiol. 2014; 114: 1049–52. DOI: 10.1016/j.amjcard.2014.07.015Chatterjee S., Bavishi C., Sardar P., Agarwal V., Krishnamoorthy P., Grodzicki T. et al. Meta-analysis of left ventricular hypertrophy and sustained arrhythmias. Am. J. Cardiol. 2014; 114: 1049–52. DOI: 10.1016/j.amjcard.2014.07.015Manolis A. J., Poulimenos L. E., Kallistratos M. S., Gavras I., Gavras H. Sympathetic overactivity in hypertension and cardiovascular disease. Curr. Vasc. Pharmacol. 2014; 12: 4–15. DOI: 10.2174/15701611113119990140Manolis A. J., Poulimenos L. E., Kallistratos M. S., Gavras I., Gavras H. Sympathetic overactivity in hypertension and cardiovascular disease. Curr. Vasc. Pharmacol. 2014; 12: 4–15. DOI: 10.2174/15701611113119990140Джанашия П. Х. Взаимосвязь структурно-функционального и электро-физиологического ремоделирования миокарда у больных артериальной гипертонией / П. Х. Джанашия [и др.] // Российский кардиологический журнал. – 2005. – 51 (1): 28–32. [Janashia P. H., Poteshkina N. G., Gaidukova N. I., Shogenov Z. S., Tuev A. V. The relationship of structural-functional and electrophysiological remodeling of the myocardium in patients with arterial hypertension. Russian Journal of Cardiology. 2005; 51 (1): 28–32. (In Russian)].Джанашия П. Х. Взаимосвязь структурно-функционального и электро-физиологического ремоделирования миокарда у больных артериальной гипертонией / П. Х. Джанашия [и др.] // Российский кардиологический журнал. – 2005. – 51 (1): 28–32. [Janashia P. H., Poteshkina N. G., Gaidukova N. I., Shogenov Z. S., Tuev A. V. The relationship of structural-functional and electrophysiological remodeling of the myocardium in patients with arterial hypertension. Russian Journal of Cardiology. 2005; 51 (1): 28–32. (In Russian)].Vaziri S. M., Larson M. G., Lauer M. S., Benjamin E. J., Levy D. Influence of blood pressure on left atrial size. The Framingham Heart Study. Hypertension. 1995; 25: 1155–60. DOI: 10.1161/01.hyp.25.6.1155Vaziri S. M., Larson M. G., Lauer M. S., Benjamin E. J., Levy D. Influence of blood pressure on left atrial size. The Framingham Heart Study. Hypertension. 1995; 25: 1155–60. DOI: 10.1161/01.hyp.25.6.1155Toh N., Kanzaki H., Nakatani S., Ohara T., Kim J., Kusano K. F. et al. Left atrial volume combined with atrial pump function identifies hypertensive patients with a history of paroxysmal atrial fibrillation. Hypertension. 2010; 55: 1150–6. DOI: 10.1161/HYPERTENSIONAHA.109.137760Toh N., Kanzaki H., Nakatani S., Ohara T., Kim J., Kusano K. F. et al. Left atrial volume combined with atrial pump function identifies hypertensive patients with a history of paroxysmal atrial fibrillation. Hypertension. 2010; 55: 1150–6. DOI: 10.1161/HYPERTENSIONAHA.109.137760Lau D. H., Shipp N. J., Kelly D. J., Thanigaimani S., Neo M., Kuklik P. et al. Atrial arrhythmia in ageing spontaneously hypertensive rats: unraveling the substrate in hypertension and ageing. PLoS One. 2013; 8: e72416. DOI: 10.1371/journal.pone.0072416Lau D. H., Shipp N. J., Kelly D. J., Thanigaimani S., Neo M., Kuklik P. et al. Atrial arrhythmia in ageing spontaneously hypertensive rats: unraveling the substrate in hypertension and ageing. PLoS One. 2013; 8: e72416. DOI: 10.1371/journal.pone.0072416Pluteanu F., Heß J., Plackic J., Nikonova Y., Preisenberger J., Bukowska A. et al. Early subcellular Ca<sup>2+</sup> remodelling and increased propensity for Ca<sup>2+</sup> alternans in left atrial myocytes from hypertensive rats. Cardiovasc. Res. 2015; 106: 87–97. DOI: 10.1093/cvr/cvv045Pluteanu F., Heß J., Plackic J., Nikonova Y., Preisenberger J., Bukowska A. et al. Early subcellular Ca<sup>2+</sup> remodelling and increased propensity for Ca<sup>2+</sup> alternans in left atrial myocytes from hypertensive rats. Cardiovasc. Res. 2015; 106: 87–97. DOI: 10.1093/cvr/cvv045Moore-Morris T., Cattaneo P., Puceat M., Evans S. M. Origins of cardiac fibroblasts. J. Mol. Cell. Cardiol. 2016; 91: 1–5. DOI: 10.1016/j.yjmcc.2015.12.031Moore-Morris T., Cattaneo P., Puceat M., Evans S. M. Origins of cardiac fibroblasts. J. Mol. Cell. Cardiol. 2016; 91: 1–5. DOI: 10.1016/j.yjmcc.2015.12.031Dzeshka M. S., Lip G. Y. H., Snezhitskiy V., Shantsila E. Cardiac fibrosis in patients with atrial fi brillation: mechanisms and clinical implications. J. Am. Coll. Cardiol. 2015; 66: 943–59. DOI: 10.1016/j.jacc.2015.06.1313Dzeshka M. S., Lip G. Y. H., Snezhitskiy V., Shantsila E. Cardiac fibrosis in patients with atrial fi brillation: mechanisms and clinical implications. J. Am. Coll. Cardiol. 2015; 66: 943–59. DOI: 10.1016/j.jacc.2015.06.1313Polejaeva I. A., Ranjan R., Davies C. J., Regouski M., Hall J., Olsen A. L. et al. Increased susceptibility to atrial fibrillation secondary to atrial fibrosis in transgenic goats expressing transforming growth Factor-β1. J. Cardiovasc. Electrophysiol. 2016; 27: 1220–1229. DOI: 10.1111/jce.13049Polejaeva I. A., Ranjan R., Davies C. J., Regouski M., Hall J., Olsen A. L. et al. Increased susceptibility to atrial fibrillation secondary to atrial fibrosis in transgenic goats expressing transforming growth Factor-β1. J. Cardiovasc. Electrophysiol. 2016; 27: 1220–1229. DOI: 10.1111/jce.13049Milliez P., Girerd X., Plouin P.-F., Blacher J., Safar M. E., Mourad J. J. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J. Am. Coll. Cardiol. 2005; 45: 1243–8. DOI: 10.1016/j.jacc.2005.01.015Milliez P., Girerd X., Plouin P.-F., Blacher J., Safar M. E., Mourad J. J. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J. Am. Coll. Cardiol. 2005; 45: 1243–8. DOI: 10.1016/j.jacc.2005.01.015Heijman J., Algalarrondo V., Voigt N., Melka J., Wehrens X. H. T., Dobrev D. et al. The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis. Cardiovasc. Res. 2016; 109: 467–79.Heijman J., Algalarrondo V., Voigt N., Melka J., Wehrens X. H. T., Dobrev D. et al. The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis. Cardiovasc. Res. 2016; 109: 467–79.Heijman J., Voigt N., Nattel S., Dobrev D. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circ. Res. 2014; 114: 1483–99. DOI: 10.1161/CIRCRESAHA.114.302226Heijman J., Voigt N., Nattel S., Dobrev D. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circ. Res. 2014; 114: 1483–99. DOI: 10.1161/CIRCRESAHA.114.302226Seccia T. M., Caroccia B., Muiesan M. L., Rossi G. P. Atrial fibrillation and arterial hypertension: a common duet with dangerous consequences where the renin angiotensin-aldosterone system plays an important role. Int. J. Cardiol. 2016; 206: 71–6. DOI: 10.1016/j.ijcard.2016.01.007Seccia T. M., Caroccia B., Muiesan M. L., Rossi G. P. Atrial fibrillation and arterial hypertension: a common duet with dangerous consequences where the renin angiotensin-aldosterone system plays an important role. Int. J. Cardiol. 2016; 206: 71–6. DOI: 10.1016/j.ijcard.2016.01.007Martins R. P., Kaur K., Hwang E., Ramirez R. J., Willis B. C., Filguei ras-Rama D. et al. Dominant frequency increase rate predicts transition from paroxysmal to long-term persistent atrial fibrillation. Circulation. 2014; 129: 1472–82. DOI: 10.1161/CIRCULATIONAHA.113.004742Martins R. P., Kaur K., Hwang E., Ramirez R. J., Willis B. C., Filguei ras-Rama D. et al. Dominant frequency increase rate predicts transition from paroxysmal to long-term persistent atrial fibrillation. Circulation. 2014; 129: 1472–82. DOI: 10.1161/CIRCULATIONAHA.113.004742Григорян С. В. Миокардиальный фиброз и фибрилляция предсердий / С. В. Григорян, Л. Г. Азарапетян, К. Г. Адамян // Российский кардиологический журнал. – 2018. – 9: 71–76. [Grigoryan S. V., Azarapetyan L. G., Adamyan K. G. Myocardial fibrosis and atrial fi brillation. Russian Jornal of Cardiology. 2018; 9: 71–76. (In Russian)]. DOI: 10.15829/1560-4071-2018-9-71-76Григорян С. В. Миокардиальный фиброз и фибрилляция предсердий / С. В. Григорян, Л. Г. Азарапетян, К. Г. Адамян // Российский кардиологический журнал. – 2018. – 9: 71–76. [Grigoryan S. V., Azarapetyan L. G., Adamyan K. G. Myocardial fibrosis and atrial fi brillation. Russian Jornal of Cardiology. 2018; 9: 71–76. (In Russian)]. DOI: 10.15829/1560-4071-2018-9-71-76Киргизова М. А. Фибрилляция предсердий и артериальная гипертензия: современное представление о патогенезе, диагностике и лечении / М. А. Киргизова [и др.] // Сибирский медиинский журнал. – 2019. –34 (3): 13–20. [Kirgizova M. A., Batalov R. E., Tatarsky B. A., Popov S. V. Atrial fibrillation and arterial hypertension: modern understanding of pathogenesis, diagnosis and treatment. Siberian Medical Journal. 2019; 34 (3): 13–20. (In Russian)]. DOI: 10.29001/2073-8552-2019-34-3-13-20Киргизова М. А. Фибрилляция предсердий и артериальная гипертензия: современное представление о патогенезе, диагностике и лечении / М. А. Киргизова [и др.] // Сибирский медиинский журнал. – 2019. –34 (3): 13–20. [Kirgizova M. A., Batalov R. E., Tatarsky B. A., Popov S. V. Atrial fibrillation and arterial hypertension: modern understanding of pathogenesis, diagnosis and treatment. Siberian Medical Journal. 2019; 34 (3): 13–20. (In Russian)]. DOI: 10.29001/2073-8552-2019-34-3-13-20Varela M., Bisbal F., Zacur E., Berruezo A., Aslanidi O. V., Mont L. et al. Novel сomputational аnalysis of left atrial anatomy improves prediction of atrial fibrillation recurrence after ablation. Front. Physiol. 2017; 8: 68. DOI: 10.3389/fphys.2017.00068Varela M., Bisbal F., Zacur E., Berruezo A., Aslanidi O. V., Mont L. et al. Novel сomputational аnalysis of left atrial anatomy improves prediction of atrial fibrillation recurrence after ablation. Front. Physiol. 2017; 8: 68. DOI: 10.3389/fphys.2017.00068Bisbal F., Alarcon F., Ferrero-de-Loma-Osorio A., Gonzalez-Ferrer J. J., Alonso C., Pachón M. et al. Left atrial geometry and outcome of atrial fibrillation ablation: results from the multicentre LAGO-AF Study. Eur. Heart J. Cardiovasc. Imaging. 2018; 19 (9): 1002–1009. DOI: 10.1093/ehjci/jey060Bisbal F., Alarcon F., Ferrero-de-Loma-Osorio A., Gonzalez-Ferrer J. J., Alonso C., Pachón M. et al. Left atrial geometry and outcome of atrial fibrillation ablation: results from the multicentre LAGO-AF Study. Eur. Heart J. Cardiovasc. Imaging. 2018; 19 (9): 1002–1009. DOI: 10.1093/ehjci/jey060Яковлев Г. М. Звуковой метод измерения артериального давления Н. С. Короткова и взгляды Н. Н. Савицкого / Г. М. Яковлев // Артериальная гипертензия. – 2005. – 11 (2): 79–81. [Yakovlev G. M. Sound method of measuring blood pressure N. S. Korotkov and the views of N. N. Savitsky. Arterial hypertension. 2005; 11 (2): 79–81. (In Russian)] .Яковлев Г. М. Звуковой метод измерения артериального давления Н. С. Короткова и взгляды Н. Н. Савицкого / Г. М. Яковлев // Артериальная гипертензия. – 2005. – 11 (2): 79–81. [Yakovlev G. M. Sound method of measuring blood pressure N. S. Korotkov and the views of N. N. Savitsky. Arterial hypertension. 2005; 11 (2): 79–81. (In Russian)] .Романовская А. М. Физические и метрологические аспекты методов измерения артериального давления с применением компрессионной манжеты / А. М. Романовская, В. М. Романовский // Мир измерений. – 2018. – 2: 33–43. [Romanovskaya A. M., Romanovsky V. M. Physical and metrological aspects of blood pressure measurement methods with the use of a compression cuff . The world of dimensions. 2018; 2: 33–43. (In Russian)].Романовская А. М. Физические и метрологические аспекты методов измерения артериального давления с применением компрессионной манжеты / А. М. Романовская, В. М. Романовский // Мир измерений. – 2018. – 2: 33–43. [Romanovskaya A. M., Romanovsky V. M. Physical and metrological aspects of blood pressure measurement methods with the use of a compression cuff . The world of dimensions. 2018; 2: 33–43. (In Russian)].Цатурян А. К. Квазикоротковский метод определения артериального давления крови / А. К. Цатурян // Мир измерений. – 2018. – 3: 34–35. [Tsaturyan A. K. Quasi-Korotkov method for determining blood pressure. The world of dimensions. 2018; 3: 34–35. (In Russian)] .Цатурян А. К. Квазикоротковский метод определения артериального давления крови / А. К. Цатурян // Мир измерений. – 2018. – 3: 34–35. [Tsaturyan A. K. Quasi-Korotkov method for determining blood pressure. The world of dimensions. 2018; 3: 34–35. (In Russian)] .Reclinghausen H. Blutdruckmessung und Kreislauf in den Arterien des Menschen. Dresden, Leipzig, 1940: 455.Reclinghausen H. Blutdruckmessung und Kreislauf in den Arterien des Menschen. Dresden, Leipzig, 1940: 455.Савицкий Н. Н. Кровяное давление и состояние сосудистой стенки в условиях нормального и патологического кровоoбращения (теория звукового метода) / Н. Н. Савицкий // Физиологический журнал СССР. – 1936. – 20 (1): 3–15. [Savitsky N. N. Blood pressure and the state of the vascular wall in conditions of normal and pathological blood circulation (theory of the sound method). Physiol. journal USSR. 1936; 20 (1): 3–15. (In Russian)].Савицкий Н. Н. Кровяное давление и состояние сосудистой стенки в условиях нормального и патологического кровоoбращения (теория звукового метода) / Н. Н. Савицкий // Физиологический журнал СССР. – 1936. – 20 (1): 3–15. [Savitsky N. N. Blood pressure and the state of the vascular wall in conditions of normal and pathological blood circulation (theory of the sound method). Physiol. journal USSR. 1936; 20 (1): 3–15. (In Russian)].Руководство по артериальной гипертонии / Под ред. Е. И. Чазова, И. Е. Чазовой. – М., Media Medica, 2005. – 784. [Guidelines for arterial hypertension. Edited by E. I. Chazov, I. E. Chazova. M., Media Medica, 2005: 784. (In Russian)].Руководство по артериальной гипертонии / Под ред. Е. И. Чазова, И. Е. Чазовой. – М., Media Medica, 2005. – 784. [Guidelines for arterial hypertension. Edited by E. I. Chazov, I. E. Chazova. M., Media Medica, 2005: 784. (In Russian)].Дегтярев В. А. Использование во врачебной практике аускультативного метода измерения артериального давления как угроза здоровью и жизни больных / В. А. Дегтярев // Терапия. – 2019. – 1: 112–118. [Degtyarev V. A. The use in medical practice of the auscultative method of measuring blood pressure as a threat to the health and life of patients. Therapy. 2019; 1: 112–118. (In Russian)]. DOI: 10.18565/therapy.2019.1.112-118Дегтярев В. А. Использование во врачебной практике аускультативного метода измерения артериального давления как угроза здоровью и жизни больных / В. А. Дегтярев // Терапия. – 2019. – 1: 112–118. [Degtyarev V. A. The use in medical practice of the auscultative method of measuring blood pressure as a threat to the health and life of patients. Therapy. 2019; 1: 112–118. (In Russian)]. DOI: 10.18565/therapy.2019.1.112-118Sykes D., Dewar R., Mohanaruban K., Donovan K., Nicklason F., Thomas D. M., Fisher D. Measuring blood pressure in the elderly: does atrial fi brillation increase observer variability? BMJ. 1990; 300 (6718): 162–3. DOI: 10.1136/bmj.300.6718.162Sykes D., Dewar R., Mohanaruban K., Donovan K., Nicklason F., Thomas D. M., Fisher D. Measuring blood pressure in the elderly: does atrial fi brillation increase observer variability? BMJ. 1990; 300 (6718): 162–3. DOI: 10.1136/bmj.300.6718.162Кобалава Ж. Д. Артериальная гипертензия у взрослых. Клинические рекомендации 2020 / Ж. Д. Кобалова [и др.] // Российский кардиологический журнал. – 2020. –25 (3): 3786. [Kobalava Zh. D., Konradi A. O., Nedogoda S. V., Shlyakhto E. V., Arutyunov G. P., Baranova E. I., Barbarash O. L., Boitsov S. A., Vavilova T. V., Villevalde S. V., Galyavich A. S., Glezer M. G., Grineva E. N., Grinstein Yu. I., Drapkina O. M., Zhernakova Y. V., Zvartau N. E., Kislyak O. A., Koziolova N. A., Kosmacheva E. D., Kotovskaya Y. V., Libis R. A., Lopatin Y. M., Nebieridze D. V., Nedoshivin A. O., Ostroumova O. D., Oschepkova E. V., Ratova L. G., Skibitsky V. V., Tkacheva O. N., Chazova I. E., Chesnikova A. I., Chumakova G. A., Shalnova S. A., Shestakova M. V., Yakushin S. S., Yanishevsky S. N. Arterial hypertension in adults. Clinical Guidelines 2020. Russian Journal of Cardiology. 2020; 25 (3): 3786. (In Russian)]. DOI: 10.15829/1560-4071-2020-3-3786Кобалава Ж. Д. Артериальная гипертензия у взрослых. Клинические рекомендации 2020 / Ж. Д. Кобалова [и др.] // Российский кардиологический журнал. – 2020. –25 (3): 3786. [Kobalava Zh. D., Konradi A. O., Nedogoda S. V., Shlyakhto E. V., Arutyunov G. P., Baranova E. I., Barbarash O. L., Boitsov S. A., Vavilova T. V., Villevalde S. V., Galyavich A. S., Glezer M. G., Grineva E. N., Grinstein Yu. I., Drapkina O. M., Zhernakova Y. V., Zvartau N. E., Kislyak O. A., Koziolova N. A., Kosmacheva E. D., Kotovskaya Y. V., Libis R. A., Lopatin Y. M., Nebieridze D. V., Nedoshivin A. O., Ostroumova O. D., Oschepkova E. V., Ratova L. G., Skibitsky V. V., Tkacheva O. N., Chazova I. E., Chesnikova A. I., Chumakova G. A., Shalnova S. A., Shestakova M. V., Yakushin S. S., Yanishevsky S. N. Arterial hypertension in adults. Clinical Guidelines 2020. Russian Journal of Cardiology. 2020; 25 (3): 3786. (In Russian)]. DOI: 10.15829/1560-4071-2020-3-3786Beevers D. G., Lip G. Y. H., O’Brien E. Measurement of blood pressure. Part 4. ABC of Hypertension. Fifth edition. BMJ. Oxford: Blackwell Publishing UK; 2007: 1–32.Beevers D. G., Lip G. Y. H., O’Brien E. Measurement of blood pressure. Part 4. ABC of Hypertension. Fifth edition. BMJ. Oxford: Blackwell Publishing UK; 2007: 1–32.Гориева Ш. Б. Точность измерения артериального давления при постоянной форме фибрилляции предсердий / Ш. Б. Гориева, А. Н. Рогоза // РМЖ. – 2013. – (12): 629–640. [Gorieva Sh. B., Rogoza A. N. Accuracy of blood pressure measurement with a constant form of atrial fibrillation. RMZH. 2013; (12): 629-640. (In Russian)].Гориева Ш. Б. Точность измерения артериального давления при постоянной форме фибрилляции предсердий / Ш. Б. Гориева, А. Н. Рогоза // РМЖ. – 2013. – (12): 629–640. [Gorieva Sh. B., Rogoza A. N. Accuracy of blood pressure measurement with a constant form of atrial fibrillation. RMZH. 2013; (12): 629-640. (In Russian)].Pickering T. G., Hall J. E., Appel L. J. et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the american heart association council on high blood pressure research. Circulation. 2005; 111 (5): 697–716. URL: https://www.ahajournals.org/doi/full/10.1161/01.CIR.0000154900.76284.F6Pickering T. G., Hall J. E., Appel L. J. et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the american heart association council on high blood pressure research. Circulation. 2005; 111 (5): 697–716. URL: https://www.ahajournals.org/doi/full/10.1161/01.CIR.0000154900.76284.F6James G. D., Gerber L. M. Measuring arterial blood pressure in humans: Auscultatory and automatic measurement techniques for human biological field studies. Am. J. Hum. Biol. 2018; 30 (1). DOI: 10.1002/ajhb.23063James G. D., Gerber L. M. Measuring arterial blood pressure in humans: Auscultatory and automatic measurement techniques for human biological field studies. Am. J. Hum. Biol. 2018; 30 (1). DOI: 10.1002/ajhb.23063Almeida L., Amado P., Vasconcelos N. et al. Sera que a monitorizacao ambulatoria da pressao arterial e fiavel nosdoentes hipertensos com fibrilhacao auricular. Rev. Port. Cardiol. 2001; 20 (6): 647–650.Almeida L., Amado P., Vasconcelos N. et al. Sera que a monitorizacao ambulatoria da pressao arterial e fiavel nosdoentes hipertensos com fibrilhacao auricular. Rev. Port. Cardiol. 2001; 20 (6): 647–650.Chibisov S., Katinas George, Brodskaya Inna. Chronobiological analysis of blood pressure in a patient with atrial fibrillation at the development of heart failure and its therapeutic and surgical treatment. Cardiology Research and Practice, 2013; ID 490705: 16. DOI: 10.1155/2013/490705Chibisov S., Katinas George, Brodskaya Inna. Chronobiological analysis of blood pressure in a patient with atrial fibrillation at the development of heart failure and its therapeutic and surgical treatment. Cardiology Research and Practice, 2013; ID 490705: 16. DOI: 10.1155/2013/490705Stergiou G. S., Kollias A., Destounis A., Tzamouranis D. Automated blood pressure measurement in atrial fibrillation: a systematic review and meta-analysis. J. Hypertens. 2012; 30: 2074–82. DOI: 10.1097/HJH.0b013e32835850d7. PMID: 22914573Stergiou G. S., Kollias A., Destounis A., Tzamouranis D. Automated blood pressure measurement in atrial fibrillation: a systematic review and meta-analysis. J. Hypertens. 2012; 30: 2074–82. DOI: 10.1097/HJH.0b013e32835850d7. PMID: 22914573Pagonas N., Schmidt S., Eysel J. et al. Impact of atrial fibrillation on the accuracy of oscillometric blood pressure monitoring. Hypertension. 2013; 62: 579–84. DOI: 10.1161/HYPERTENSIONAHA.113.01426Pagonas N., Schmidt S., Eysel J. et al. Impact of atrial fibrillation on the accuracy of oscillometric blood pressure monitoring. Hypertension. 2013; 62: 579–84. DOI: 10.1161/HYPERTENSIONAHA.113.01426Lakhal K., Ehrmann S., Martin M., Faiz S., Réminiac F., Cinotti I. R., Capdevila X., Asehnoune K., Blanloeil Y., Rozec B., Boulain T. Blood pressure monitoring during arrhythmia: agreement between automated brachial cuff and intra-arterial measurements. British J. Anaesthesia. 2015; 115 (4): 540–9. DOI: 10.1093/bja/aev304Lakhal K., Ehrmann S., Martin M., Faiz S., Réminiac F., Cinotti I. R., Capdevila X., Asehnoune K., Blanloeil Y., Rozec B., Boulain T. Blood pressure monitoring during arrhythmia: agreement between automated brachial cuff and intra-arterial measurements. British J. Anaesthesia. 2015; 115 (4): 540–9. DOI: 10.1093/bja/aev304

The authors declare that there are no conflicts of interest present.